241 related articles for article (PubMed ID: 23933151)
1. PELP1: a review of PELP1 interactions, signaling, and biology.
Girard BJ; Daniel AR; Lange CA; Ostrander JH
Mol Cell Endocrinol; 2014 Jan; 382(1):642-651. PubMed ID: 23933151
[TBL] [Abstract][Full Text] [Related]
2. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
[TBL] [Abstract][Full Text] [Related]
3. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells.
Chakravarty D; Nair SS; Santhamma B; Nair BC; Wang L; Bandyopadhyay A; Agyin JK; Brann D; Sun LZ; Yeh IT; Lee FY; Tekmal RR; Kumar R; Vadlamudi RK
Cancer Res; 2010 May; 70(10):4092-101. PubMed ID: 20460518
[TBL] [Abstract][Full Text] [Related]
4. Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR.
Vadlamudi RK; Kumar R
Nucl Recept Signal; 2007 May; 5():e004. PubMed ID: 17525794
[TBL] [Abstract][Full Text] [Related]
5. Cancer Stem Cell Phenotypes in ER
Truong TH; Hu H; Temiz NA; Hagen KM; Girard BJ; Brady NJ; Schwertfeger KL; Lange CA; Ostrander JH
Mol Cancer Res; 2018 Apr; 16(4):707-719. PubMed ID: 29348189
[TBL] [Abstract][Full Text] [Related]
6. Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.
Manavathi B; Nair SS; Wang RA; Kumar R; Vadlamudi RK
Cancer Res; 2005 Jul; 65(13):5571-7. PubMed ID: 15994929
[TBL] [Abstract][Full Text] [Related]
7. Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.
Rajhans R; Nair HB; Nair SS; Cortez V; Ikuko K; Kirma NB; Zhou D; Holden AE; Brann DW; Chen S; Tekmal RR; Vadlamudi RK
Mol Endocrinol; 2008 Mar; 22(3):649-64. PubMed ID: 18079323
[TBL] [Abstract][Full Text] [Related]
8. Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.
Nair SS; Mishra SK; Yang Z; Balasenthil S; Kumar R; Vadlamudi RK
Cancer Res; 2004 Sep; 64(18):6416-23. PubMed ID: 15374949
[TBL] [Abstract][Full Text] [Related]
9. Emerging significance of ER-coregulator PELP1/MNAR in cancer.
Nair S; Vadlamudi RK
Histol Histopathol; 2007 Jan; 22(1):91-6. PubMed ID: 17128415
[TBL] [Abstract][Full Text] [Related]
10. Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1).
Gururaj AE; Peng S; Vadlamudi RK; Kumar R
Mol Endocrinol; 2007 Aug; 21(8):1847-60. PubMed ID: 17505058
[TBL] [Abstract][Full Text] [Related]
11. PELP1--a novel estrogen receptor-interacting protein.
Brann DW; Zhang QG; Wang RM; Mahesh VB; Vadlamudi RK
Mol Cell Endocrinol; 2008 Aug; 290(1-2):2-7. PubMed ID: 18571832
[TBL] [Abstract][Full Text] [Related]
12. Cloning and functional characterization of PELP1/MNAR promoter.
Mishra SK; Balasenthil S; Nguyen D; Vadlamudi RK
Gene; 2004 Apr; 330():115-22. PubMed ID: 15087130
[TBL] [Abstract][Full Text] [Related]
13. Regulation of aromatase induction by nuclear receptor coregulator PELP1.
Vadlamudi RK; Rajhans R; Chakravarty D; Nair BC; Nair SS; Evans DB; Chen S; Tekmal RR
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):211-8. PubMed ID: 19800002
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.
Rajhans R; Nair S; Holden AH; Kumar R; Tekmal RR; Vadlamudi RK
Cancer Res; 2007 Jun; 67(11):5505-12. PubMed ID: 17545633
[TBL] [Abstract][Full Text] [Related]
15. Cloning, distribution, and colocalization of MNAR/PELP1 with glucocorticoid receptors in primate and nonprimate brain.
Khan MM; Hadman M; De Sevilla LM; Mahesh VB; Buccafusco J; Hill WD; Brann DW
Neuroendocrinology; 2006; 84(5):317-29. PubMed ID: 17142998
[TBL] [Abstract][Full Text] [Related]
16. Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer.
Cortez V; Mann M; Tekmal S; Suzuki T; Miyata N; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Vadlamudi RK
Breast Cancer Res; 2012 Jul; 14(4):R108. PubMed ID: 22812534
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.
Balasenthil S; Vadlamudi RK
J Biol Chem; 2003 Jun; 278(24):22119-27. PubMed ID: 12682072
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.
Vadlamudi RK; Balasenthil S; Broaddus RR; Gustafsson JA; Kumar R
J Clin Endocrinol Metab; 2004 Dec; 89(12):6130-8. PubMed ID: 15579769
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.
Vadlamudi RK; Wang RA; Mazumdar A; Kim Y; Shin J; Sahin A; Kumar R
J Biol Chem; 2001 Oct; 276(41):38272-9. PubMed ID: 11481323
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains.
Choi YB; Ko JK; Shin J
J Biol Chem; 2004 Dec; 279(49):50930-41. PubMed ID: 15456770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]